Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-522.49%
operating margin TTM
-548.12%
revenue TTM
37.54 Million
revenue per share TTM
0.82$
valuation ratios | |
|---|---|
| pe ratio | -18.82 |
| peg ratio | 1.21 |
| price to book ratio | 12.55 |
| price to sales ratio | 98.36 |
| enterprise value multiple | -19.01 |
| price fair value | 12.55 |
profitability ratios | |
|---|---|
| gross profit margin | 87.83% |
| operating profit margin | -548.12% |
| pretax profit margin | -522.49% |
| net profit margin | -522.49% |
| return on assets | -52.39% |
| return on equity | -62.71% |
| return on capital employed | -69.8% |
liquidity ratios | |
|---|---|
| current ratio | 4.37 |
| quick ratio | 4.37 |
| cash ratio | 0.82 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 1.62 |
| days of payables outstanding | 1,078.54 |
| cash conversion cycle | -1,076.92 |
| receivables turnover | 225.06 |
| payables turnover | 0.34 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -50.76 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.23 |
| cash per share | 2.69 |
| operating cash flow per share | -1.16 |
| free cash flow operating cash flow ratio | 1.06 |
| cash flow coverage ratios | -50.76 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -15.66 |
Frequently Asked Questions
When was the last time Capricor Therapeutics, Inc. (NASDAQ:CAPR) reported earnings?
Capricor Therapeutics, Inc. (CAPR) published its most recent earnings results on 10-11-2025.
What is Capricor Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Capricor Therapeutics, Inc. (NASDAQ:CAPR)'s trailing twelve months ROE is -62.71%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Capricor Therapeutics, Inc. (CAPR) currently has a ROA of -52.39%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CAPR's net profit margin stand at?
CAPR reported a profit margin of -522.49% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CAPR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.37 in the most recent quarter. The quick ratio stood at 4.37, with a Debt/Eq ratio of 0.01.